2. It's even arguable that his price hikes hurt anyone other than already rich insurance monopolies. The insurance companies would have had to cover the prices, and any people without insurance could have received the drug for free from their company. And of course the higher profits went into upgrading the drug.
Also what upgraded version has been released? I haven't found any PubMed/FDA studies mentioning any improvements nor any studies funded by the company. Can you point me to some?
It is a uniquely American perspective to assume that insurance companies are some abstracted layer of infinite money that individual people needn't worry about. But then, everyone complains about insurance premiums and they wonder why they can't be lower. What irony.
It's amazing how Europeans expect Pharmaceutical companies to invest R&D into rarely used drugs when they can't make a profit.